loader
Please Wait
Applying Filters...

Metrochem API Private Limited Metrochem API Private Limited

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2022_178___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    DONG BANG FUTURE TECH & LIFE CO., LTD

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Veranova: A CDMO that manages complexity with confidence.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 DONG BANG FUTURE TECH & LIFE CO., LTD. Hwaseong-si KR (1)

    filter

    01 Tamsulosin hydrochloride (1)

    filter

    01 South Korea (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    DONG BANG FUTURE TECH & LIFE CO., L...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag South Korea
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Tamsulosin hydrochloride

      PDF Supplier PDF
      URL Supplier Web Content
      CEP 2022-178 - Rev 00
      Valid
      Chemical
      2024-04-16
      2131
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for CEP 2022-178 - Rev 00 of Dong Bang Future Tech & Life Co., Ltd. Hwaseong-si Kr

      Looking for Certificates of Suitability (CEPs) for CEP 2022-178 - Rev 00 of Dong Bang Future Tech & Life Co., Ltd. Hwaseong-si Kr 1

      20

      Dong Bang Future Tech & Life Co., Ltd. Hwaseong-si Kr, based in South Korea, is a pharmaceutical company.

      One of their significant offerings is Tamsulosin hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-178 - Rev 00

      This Chemical Type CEP, issued on April 16, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

      Substance Number 2131 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY